Organon Missed Consensus Estimates

Organon (OGN) reported earnings of $0.80 per share on revenue of $1.56 billion for the second quarter ended June 2026. The consensus earnings estimate was $0.85 per share. The company missed consensus estimates by 5.88% while revenue fell 2.26% compared to the same quarter a year ago.

Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives.